ReviewJournal of robotic surgery2026
Global trends and emerging frontiers in robot-assisted vascular intervention: a comprehensive bibliometric analysis.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Robot-assisted vascular intervention may reduce occupational radiation exposure, improve procedural stability, and expand access to specialized endovascular care, but its global research landscape and developmental trajectory remain unclear. Publications related to robot-assisted vascular intervention were retrieved from the Web of Science Core Collection from January 1, 2006, to February 28, 2026. After screening according to predefined inclusion and exclusion criteria, 161 eligible articles were included. Bibliometric and visual analyses were performed using VOSviewer and CiteSpace to evaluate publication trends, countries, institutions, journals, authors, citation patterns, keyword co-occurrence, thematic clusters, and emerging hotspots. Annual publications increased markedly after 2020 and peaked in 2024. Reviews (29.8%) and observational clinical studies (26.7%) predominated, whereas randomized controlled trials remained scarce (1.9%). CorPath GRX was the most frequently reported robot-assisted vascular intervention platform, while the emergence of ETcath200 and others newer systems reflected increasing global platform diversification. The United States was the leading contributor, followed by China and the United Kingdom. The University of California System, Houston Methodist, and the University of Toronto were the most productive institutions. Highly cited studies were dominated by the studies of robotic-assisted percutaneous coronary intervention, although peripheral and neurointerventional applications have become increasingly prominent. Keyword analyses suggested an evolution from early feasibility, safety, and radiation-protection concerns toward broader clinical translation, remote intervention, artificial intelligence, and autonomous navigation. Robot-assisted vascular intervention is a rapidly expanding, multidisciplinary field, but its evidence base remains relatively immature. Future research should emphasize multicenter validation, cross-specialty collaboration, procedural standardization, and intelligent robotic assistance to support safer and more reproducible endovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.